// App-Quantinova.ai

OC 02.5 : In vivo murine studies demonstrate that neutrophil activation by anti-NAP2 antibodies contributes to vaccine-induced immune thrombocytopenia and thrombosis (VITT)

Researchers

Presenter

  • C. Field

Principal Investigators

  • H. Kim

  • G. Arepally

  • L. Rauova

Medical Centers

  • 3University of Pennsylvania - Children’S Hospital of Philadelphia Philadelphia PA United States

  • The Childrenaaas Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

  • Department of Neurology, Duke University Medical Center, Durham, North Carolina, United States

  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Immune thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Platelet Factor 4

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved